retatrutide study results Shows Promising in Type 2 Diabetes and Obesity Trial | Michael Weintraub, MD posted on the topic retatrutide weight loss clinical trials

Renal hemodynamic effects of glucagon-like peptide-1 agonist are mediated by nitric oxide but not prostaglandin

doi: 10.1016/j.freeradbiomed.2024.11.040 22 KanemitsuTTsurudomeYKusunoseNOdaMMatsunagaNKoyanagiSet al

Patient initiation and maintenance of GLP-1 RAs for treatment of obesity

Cardiorenal protective effects of glucagon-like peptide-1 receptor agonists in chronic kidney disease: a systematic review and meta-analysis

He said that in his practice, he hasnt come across anyone experiencing suicidal thoughts after taking a GLP-1 drug, but noted its important for any physician prescribing these medications to do a mental health screening

Conclusion Real transformation isnt found in trendsits built through science, consistency, and care